Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

Viral Infections, Non-HIV

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients

Emerg Infect Dis.

Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL

doi: 10.3201/eid2607.200841.

Viral Infections, Non-HIV

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Emerg Infect Dis.

Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, Wang L, Whitaker B, Lynch B, Gautam R, Schindewolf C, Lokugamage KG, Scharton D, Plante JA, Mirchandani D, Widen SG, Narayanan K, Makino S, Ksiazek TG, Plante KS, Weaver SC, Lindstrom S, Tong S, Menachery VD, Thornburg NJ

doi: 10.3201/eid2606.200516.

Viral Infections, Non-HIV

Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2

Emerg Infect Dis.

Frieden TR, Lee CT

doi: 10.3201/eid2606.200495.

Viral Infections, Non-HIV

Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019

Clin Infect Dis

Lee JS, Kim SY, Kim TS, Hong KH, Ryoo NH, Lee J, Park JH, Cho SI, Kim MJ, Kim YG, Kim B, Shin HS, Oh HS, Seo MS, Gwon TR, Kim Y, Park JS, Chin BS, Park WB, Park SS, Seong MW

doi: 10.1093/cid/ciaa1421

Viral Infections, Non-HIV

Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2

Emerg Infect Dis.

Waggoner JJ, Stittleburg V, Pond R, Saklawi Y, Sahoo MK, Babiker A, Hussaini L, Kraft CS, Pinsky BA, Anderson EJ, Rouphael N

doi: 10.3201/eid2607.201285.

Viral Infections, Non-HIV

Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe

Emerg Infect Dis.

Olsen SJ, Chen MY, Liu YL, Witschi M, Ardoin A, Calba C, Mathieu P, Masserey V, Maraglino F, Marro S, Penttinen P, Robesyn E, Pukkila J, European COVID-19 Work Group.

doi: 10.3201/eid2607.200359.

Viral Infections, Non-HIV

Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020

Emerg Infect Dis.

Arima Y, Shimada T, Suzuki M, Suzuki T, Kobayashi Y, Tsuchihashi Y, Nakamura H, Matsumoto K, Takeda A, Kadokura K, Sato T, Yahata Y, Nakajima N, Tobiume M, Takayama I, Kageyama T, Saito S, Nao N, Matsui T, Sunagawa T, Hasegawa H, Ohnishi M, Wakita T

doi: 10.3201/eid2607.200994.

Viral Infections, Non-HIV

Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020

Emerg Infect Dis.

Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, Cui Y, Fu RB, Dong YZ, Chi XY, Zhang MY, Liu K, Cao C, Liu B, Zhang K, Gao YW, Lu B, Chen W

doi: 10.3201/eid2607.200885.

Viral Infections, Non-HIV

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clin Infect Dis.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D

doi: 10.1093/cid/ciaa237.

Related content

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2

Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019

Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2

Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe

Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020

Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)